Experimental pulmonary fibrosis induced by Paracoccidioides brasiliensis conidia: Measurement of local host responses

American Journal of Tropical Medicine and Hygiene

Volumn 58, Issue 4, 1998, Pages 424-430

  Franco, L ^a   Najvar, L ^b   Gomez, B L ^a   Restrepo, S ^a   Graybill, J R ^c   Restrepo, A ^a  

^a Unidad de Biología Celular y Molecular   (Colombia)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; HYDROXYPROLINE; INTERLEUKIN 1; INTERLEUKIN 4; INTERLEUKIN 6; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GRANULOMA; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOREGULATION; LUNG FIBROSIS; MALE; MOUSE; NONHUMAN; PARACOCCIDIOIDES BRASILIENSIS; PATHOPHYSIOLOGY; QUANTITATIVE DIAGNOSIS;

EID: 0031940049     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.58.424     Document Type: Article

References (36)

1. Scott PA, Sher A, 1993. Immunoparasitology. Paul WE, ed. Fundamental Parasitology. Third edition. New York: Raven Press, 1179-1210.
2. Goodwin RA, Nickell JA, Dez Prez RM, 1972. Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis. Medicine 51: 227-232.
3. Brummer E, Castaneda E, Restrepo A, 1993. Paracoccidioidomycosis: an update. Clin Microbiol 6: 89-117.
4. Perez MI, Kohn S, 1993. Systemic sclerosis. J Am Acad Dermatol 28: 525-547.
5. Thrall RS, McCormick RM Jr, McReynolds RA, Ward PA, 1979. Bleomycin induced pulmonary fibrosis in the rat: inhibition by indomethacin. Am J Pathol 95: 117-127.
6. Cantin AM, Boilean R, Begin R, 1988. Increased procollagen III amino terminal peplide-related antigens and fibroblast growth signals in the lung of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 137: 572-579.
7. Crystal R, Bitterman P, Rennard SI, Hance AK, Keogh BA, 1984. Interstitial lung disease of unknown cause. Disorder characterized by chronic inflammation of the lower respiratory (first part). N Engl J Med 310: 154-166.
8. Crystal R, Bitterman P, Rennard SI, Hance AK, Keogh BA, 1984. Interstitial lung disease of unknown cause. Disorder characterized by chronic inflammation of the lower respiratory tract (second part). W Engl J Med 310: 235-244.
9. Fridman SL, 1993. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 355: 1835.
10. Bitterman PB, Rennard SI, Hunninghake G, Crystal RG, 1982. Human alveolar macrophase growth factor for fibroblasts. Regulation and partial characterization. J Clin Invest 70: 806-822.
11. Bitterman PB, Adelberg S, Crystal RG, 1983. Mechanisms of pulmonary fibrosis: spontaneous release of alveolar macrophage derived growth factor in the interstitial lung disorders. J Clin Invest 72: 1810-1813.
12. Elias JA, Freundlich B, Kern J, Rosenbloom J, 1990. Cytokine networks in the regulation of inflammation and fibrosis in the lung. Chest 97: 1439-1445.
13. Kovacs EJ, 1991. Fibrogenic cytokines: the role of the immune mediators in the development of scar tissue. Imnutnol Today 12: 17-23.
14. Maquart FX, Gillery P, Borel JP, 1994. Cytokines and fibrosis. Eur J Dermatol 4: 91-97.
15. Postlethwaite AE, Holness MA, Katai H, Raghow R, 1992. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin-4. J Clin Invest 90: 1479-1485.
16. Hunninghake GW, Kalica AR, 1995. Approaches to the treatment pulmonary fibrosis. Am J Crit Care Med 151: 915-918.
17. Gosset P, Perez T, Lasalle B, Duquesnoy B, Farre JM, Tonnel AB, Capron A, 1991. Increased TNF alpha secretion by alveolar macrophages from patients with rheumatoid arthritis. Am Rev Respir Dis 143: 593-599.
18. Piguet PF, Collart MA, Grau CE, Kapanci Y, Vassalli P, 1989. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med 170: 655-663.
19. Graybill JR, Ahrens J, Suchyta MR, Coalson J, 1988. Experimental pulmonary histoplasmosis and emphysema. Am Rev Respir Dis 137: 1193-1197.
20. Williams DM, Magee DM, Bonewald LF, Smith JG, Byrne GI, Schachter JA, 1990. Role in vivo for TNF alpha in host defense against C. trachomatis. Inject Immun 58: 1572-1577.
21. Franco MF, Mendez RP, Moscard-Bacchi M, Rezkaliah-Iwasso M, Montenegro MR, 1989. Paracoccidioidomycosis. Bailliere's Clin Trop Med Commun Dis 4: 185-220.
22. Londero AT, Severo LC, 1981. The gamut of progressive pulmonary paracoccidioidomycosis. Mycopathologia 75: 65-74.
23. Naranjo MS, Trujillo M, Munera MI, Restrepo P, Gomez I, Restrepo A, 1990. Treatment of paracoccidioidomycosis with itraconazole. J Med Vet Mycol 55: 67-76.
24. Restrepo S, Tobon AM, Trujillo J, Restrepo A, 1992. Development of pulmonary fibrosis in mice during infection with P. brasiliensis conidia. J Vet Mycol 30: 173-184.
25. Restrepo A, Salazar ME, Cano LE, Patino MM, 1986. A technique to collect and dislodge conidia produce by P. brasiliensis mycelial form. J Med Vet Mycol 24: 247-250.
26. Calich VL, Purchino A, Paula CR, 1978. A new fluorescent viability test for fungal cells. Mycopathologia 66: 175-177.
27. McEwen JG, Bedoya V, Patino MM, Salazar ME, Restrepo A, 1987. Experimental murine paracoccidioidomycosis induced by the inhalation of conidia. J Med Vet Mycol 25: 165-175.
28. Woessner JF Jr. 1961. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 93: 440-447.
29. Machado J, Miranda JL, Teixeira GA, 1965. Das sequelas da blaslomicos e Sul-Americana. Hospital 68: 141-147.
30. Tuder RM, Ibrahim R, Godoy CE, de Brito T, 1985. Pathology of human pulmonary paracoccidioidomycosis. Mycopathologia 92: 179-188.
31. Campos EP, Padovani CR, Cataneo AMJ, 1991. Paracoccidioidomicose: estudo radiologico e pulmonar de 58 casos. Rev Inst Med Trop 33: 267-276.
32. Kumar RK, Lykker AW, 1995. Messages and handshakes: cellular interactions in pulmonary fibrosis. Pathology 27: 18-26.
33. Phan SH, Kunkel SL, 1992. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Lung Res 18: 29-43.
34. Schreir DJ, Phan SH, McGarry BM, 1983. The effects of the nude (nu/nu) mutation on bleomycin produced pulmonary fibrosis. Am Rev Respir Dis 127: 614-617.
35. Wahl SM, 1992. Transforming growth factor beta in inflammation: a cause and cure. J Clin Immunol 12: 61-74.
36. Kovacs EJ, Kelley J, 1985. Lymphokine regulation of macrophage derived growth factor secretion following pulmonary injury. Am J Pathol 121: 261-268.